Skip to main content
. 2020 Apr 23;7(4):416–421. doi: 10.1093/ehjqcco/qcaa032

Figure 1.

Figure 1

Use of GDMT in the CABG plus medical therapy versus medical therapy alone arms of the Surgical Treatment for Ischemic Heart Failure trial. There was a significant difference in rates of GDMT at hospital discharge or 30 days after enrolment between the two arms. However, at subsequent follow-up, only about two-thirds of patients in both treatment arms were treated with GDMT. CABG, coronary artery bypass grafting.